AmerisourceBergen Takes Hit From PBM Specialty Pharmacy Acquisitions
This article was originally published in The Pink Sheet Daily
Executive Summary
The wholesaler predicts a “revenue shift” because of the loss of customers CuraScript and Priority Healthcare.
You may also be interested in...
Express Scripts Makes Specialty Pharmacy Portfolio A Priority Through Acquisition
Combination of CuraScript and Priority Healthcare will have sales of over $3 bil. Acquisition will provide CuraScript with access to new therapies, including those in fertility, hemophilia, home infusion, pulmonary hypertension and pulmonary fibrosis.
Novartis Institute For Tropical Diseases Could Have TB Drug In Clinic By Late 2007
Singapore-based institute is also looking at dengue fever and malaria, exec says in interview with “The Pink Sheet” DAILY.
Lilly To Settle Additional Zyprexa Liability Cases, Will Pay Up To $500 Million
Lilly will pay up to $500 million to settle the "vast majority" of claims alleging that the company failed to adequately warn patients of risks associated with the atypical antipsychotic Zyprexa (olanzapine), the firm announced Jan. 4